$166 Thousand is the total value of Kopp Family Office, LLC's 23 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 64.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWM | New | ISHARES TRrussell 2000 etf | $31,406 | – | 146,400 | +100.0% | 18.90% | – |
VEA | New | VANGUARD TAX-MANAGED FDSvan ftse dev mkt | $25,373 | – | 604,545 | +100.0% | 15.27% | – |
FIVN | Buy | Five9 Inc | $17,860 | -99.9% | 263,190 | +50.2% | 10.75% | +0.5% |
HZNP | Sell | Horizon Therapeutics Pub L | $15,579 | -100.0% | 136,895 | -74.8% | 9.38% | -65.7% |
VWO | New | VANGUARD INTL EQUITY INDEX Fftse emr mkt etf | $15,053 | – | 386,175 | +100.0% | 9.06% | – |
VCEL | Buy | Vericel Corporation | $14,709 | -99.9% | 558,413 | +1.0% | 8.85% | -15.2% |
NEO | Sell | NeoGenomics Inc | $14,011 | -99.9% | 1,516,313 | -1.5% | 8.43% | -21.8% |
JAMF | Buy | JAMF HOLDING CORP | $13,499 | -99.9% | 633,773 | +1.7% | 8.12% | -27.7% |
TEAM | New | Atlassian Corp PLCcl a | $6,714 | – | 52,179 | +100.0% | 4.04% | – |
MITK | Buy | MITEK SYS INC | $2,541 | -99.9% | 262,255 | +3.1% | 1.53% | -19.4% |
VRDN | New | Viridian Therapeutics Inc | $1,881 | – | 64,388 | +100.0% | 1.13% | – |
WK | New | Workiva Inc | $1,821 | – | 21,689 | +100.0% | 1.10% | – |
INSP | New | Inspire Med Sys Inc | $1,757 | – | 6,977 | +100.0% | 1.06% | – |
New | Coherent Corp | $1,731 | – | 49,319 | +100.0% | 1.04% | – | |
MODN | New | Model N Inc | $1,684 | – | 41,519 | +100.0% | 1.01% | – |
IEFA | Sell | ISHARES TRcore msci eafe | $157 | -100.0% | 2,547 | -99.3% | 0.09% | -99.4% |
ISTB | Sell | ISHARES TRcore 1 5 yr usd | $96 | -99.9% | 2,070 | -7.1% | 0.06% | -31.0% |
IVV | Sell | ISHARES TRcore s&p500 etf | $86 | -99.9% | 223 | -4.7% | 0.05% | -23.5% |
IEMG | Sell | ISHARES TRcore msci emkt | $68 | -100.0% | 1,455 | -99.5% | 0.04% | -99.6% |
IAGG | Sell | ISHARES TRcore intl aggr | $38 | -99.9% | 806 | -6.5% | 0.02% | -32.4% |
IMTB | ISHARES TRcr 5 10 yr etf | $36 | -99.9% | 834 | 0.0% | 0.02% | -21.4% | |
IJH | Sell | ISHARES TRcore s&p mcp etf | $27 | -99.9% | 113 | -7.4% | 0.02% | -27.3% |
IJR | Sell | ISHARES TRcore s&p scp etf | $16 | -99.9% | 164 | -3.0% | 0.01% | -16.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NeoGenomics Inc. | 16 | Q3 2023 | 90.1% |
Vericel Corporation | 16 | Q3 2023 | 14.5% |
Five9, Inc. | 16 | Q3 2023 | 11.2% |
ISHARES TR | 13 | Q3 2023 | 16.7% |
ISHARES TR | 13 | Q3 2023 | 10.6% |
ISHARES TR | 13 | Q3 2023 | 0.1% |
ISHARES TR | 13 | Q3 2023 | 0.1% |
ISHARES TR | 13 | Q3 2023 | 0.0% |
ISHARES TR | 13 | Q3 2023 | 0.0% |
ISHARES TR | 13 | Q3 2023 | 0.0% |
View Kopp Family Office, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
RTI Surgical Holdings, Inc. | July 07, 2020 | ? | ? |
NEOGENOMICS INC | January 07, 2020 | 4,844,625 | 4.6% |
OCLARO, INC. | January 04, 2019 | ? | ? |
SUPERCONDUCTOR TECHNOLOGIES INC | October 05, 2018 | ? | ? |
View Kopp Family Office, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-16 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-15 |
13F-HR | 2021-11-16 |
View Kopp Family Office, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.